5
Total investments
1
Early stage
0
Mid stage
0
Late stage
18y
Years active
Portfolio
1 investments Β· sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Sep 2019
At VentriJect, we want to change how we work with cardiorespiratory fitness.
Cardiorespiratory fitness, also expressed as VO2max, is the strongest indicator of health, according to several studies, and even small improvements in VO2max can mean a significant health improvement.
Unfortunately, evaluating cardiorespiratory fitness today can be cumbersome, time-consuming, expensive and dependent on highly-trained staff.
At VentriJect we want to change that.
Introducing the Seismofit - a radical new approach to evaluating cardiorespiratory fitness. With high accuracy, no training required, and extreme ease of use, we can estimate your VO2max in less than 3 minutes - a fraction of the time used with other approaches. This clinical-validated and patented technology is unique and a true game-changer, and will provide significant value to the patients and the healthcare practitioners.
VentriJect was established as a spin-out from a leading research center in cardiology at Aalborg University in 2018 and is situated in Hellerup near Copenhagen, Denmark.
Experience Β· 11 entries
All (11)
Investments (5)
Founder (1)
Board (5)
2019
Board Member
Sep 2019
At VentriJect, we want to change how we work with cardiorespiratory fitness.
Cardiorespiratory fitness, also expressed as VO2max, is the strongest indicator of health, according to several studies, and even small improvements in VO2max can mean a significant health improvement.
Unfortunately, evaluating cardiorespiratory fitness today can be cumbersome, time-consuming, expensive and dependent on highly-trained staff.
At VentriJect we want to change that.
Introducing the Seismofit - a radical new approach to evaluating cardiorespiratory fitness. With high accuracy, no training required, and extreme ease of use, we can estimate your VO2max in less than 3 minutes - a fraction of the time used with other approaches. This clinical-validated and patented technology is unique and a true game-changer, and will provide significant value to the patients and the healthcare practitioners.
VentriJect was established as a spin-out from a leading research center in cardiology at Aalborg University in 2018 and is situated in Hellerup near Copenhagen, Denmark.
2017
R
ResoTher Pharma ApS
Board Member
Nov 2017
2015
I
IOL Innovations ApS
Board Member
Feb 2015
2013
R
RoboTrainer
Board Member
Oct 2013
Q
Qmed Consulting
Senior Principal Advisor
Mar 2013
Show all 11 entries β
Investment activity
2008β2019 Β· 5 investments
Recent (last 2 years)Earlier
